Cross-sectional review of diabetic retinopathy prevalence and risk factors in 384 Somaliland patients
This observational, descriptive cross-sectional review assesses the prevalence of diabetic retinopathy (DR) and its associations with various risk factors in a cohort of 384 patients with diabetes mellitus attending a tertiary-care hospital in Hargeisa, Somaliland. The study population included individuals with comorbidities such as hypertension, and the analysis focused on the presence of DR as the primary outcome, with secondary outcomes detailing the type of DR, specifically non-proliferative diabetic retinopathy (NPDR) and macular oedema.
The review reports a DR prevalence of 51% (197 out of 384 patients). Among those with DR, the distribution was 17% NPDR (67 cases) and 26% macular oedema (98 cases). The authors identify several significant associations: age above 40 years was associated with DR, with a 37% lesser risk for patients aged below 40 compared to those above 40 (p=0.020). Additionally, marital status (P=0.010), employment status (P=0.002), and literacy status (P=0.020) were all significantly associated with DR presence.
Further analysis indicated that a longer duration of diabetes was strongly associated with DR, showing approximately 2 times higher chance for duration >10 years versus <10 years (p=0.001). The presence of concomitant cardiac illness was also strongly associated with DR (p=0.001). The study did not report adverse events, discontinuations, or tolerability data. The authors acknowledge that because this is an observational study, causal relationships cannot be definitively established, and effect sizes should be interpreted with caution.
Practice relevance centers on the priority of effective regular eye screening and treatment for all diabetes patients. Clinicians should recognize these associations as potential markers for risk stratification but must avoid inferring causation from these observational associations. The findings highlight the high burden of DR in this specific setting and the importance of managing comorbidities like cardiac illness and monitoring disease duration.